Zheng Ruan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zheng Ruan has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Haihua Huang
Thoracic surgery, Shanghai General Hospital, 650, Shanghai, 200080, CHINA
4 shared publicationsPeize Meng
Department of Cardiothoracic Surgery, Precision Medicine Center, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China
4 shared publicationsYuchen Wang
Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China
4 shared publicationsHansong Jin
Department of Thoracic Surgery, Shanghai General Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China
2 shared publicationsJin Wang
Department of Thoracic Surgery Shanghai First People's Hospital Shanghai China
2 shared publicationsTongtong Gu
Department of Pharmacy, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publications
Latest Publications
- Open Access
- 9 June 2026
- Published by Springer Nature in Discover Oncology
Multiomics integration prioritizes potential drug targets for lung cancer
To provide more treatment options for patients with advanced lung cancer, this study aims to identify new therapeutic drug targets via the integration and analysis of multi-omics datasets. In this study, we performed MR and co-localization analysis to identify candidate drug targets associated with lung cancer by leveraging gene expression quantitative trait loci (eQTLs) data from the eQTLGen consortium, and validated these findings orthogonally using protein expression trait loci (pQTL) data. In addition, we performed survival analysis, genetic diagnostic analysis, and differential expression analysis to further test their correlation with lung cancer. Summary-level data from ILCCO and FinnGen R9 were used as discovery datasets, and the TRICL consortium was used as an independent replication cohort. Together, we applied these methods to assess the causal relationship between these putative gene targets and lung cancer risk, and to determine whether they are associated with patient morbidity and prognosis. Among 2,645 candidate genes with robust cis-eQTL instruments, we prioritized four genes (SERPING1, THBS3, FLT4 and CHEK1) that showed strong causal associations with lung cancer risk and high posterior probabilities of co-localization (PP.H4 > 0.80) between eQTL and lung cancer GWAS signals. Genetically higher expression of SERPING1, THBS3 and FLT4 was associated with an increased risk of lung cancer, whereas higher CHEK1 expression was associated with a reduced risk. All four putative gene targets were consistently validated across independent cohorts. This multi-omics MR framework identifies genes whose genetically predicted expression is associated with increased or decreased lung cancer risk and may help prioritize candidate targets for future lung cancer drug development.
- 9 June 2026
- Published by Springer Nature in Discover Oncology
Open AccessMultiomics integration prioritizes potential drug targets for lung cancer
To provide more treatment options for patients with advanced lung cancer, this study aims to identify new therapeutic drug targets via the integration and analysis of multi-omics datasets. In this study, we performed MR and co-localization analysis to identify candidate drug targets associated with lung cancer by leveraging gene expression quantitative trait loci (eQTLs) data from the eQTLGen consortium, and validated these findings orthogonally using protein expression trait loci (pQTL) data. In addition, we performed survival analysis, genetic diagnostic analysis, and differential expression analysis to further test their correlation with lung cancer. Summary-level data from ILCCO and FinnGen R9 were used as discovery datasets, and the TRICL consortium was used as an independent replication cohort. Together, we applied these methods to assess the causal relationship between these putative gene targets and lung cancer risk, and to determine whether they are associated with patient morbidity and prognosis. Among 2,645 candidate genes with robust cis-eQTL instruments, we prioritized four genes (SERPING1, THBS3, FLT4 and CHEK1) that showed strong causal associations with lung cancer risk and high posterior probabilities of co-localization (PP.H4 > 0.80) between eQTL and lung cancer GWAS signals. Genetically higher expression of SERPING1, THBS3 and FLT4 was associated with an increased risk of lung cancer, whereas higher CHEK1 expression was associated with a reduced risk. All four putative gene targets were consistently validated across independent cohorts. This multi-omics MR framework identifies genes whose genetically predicted expression is associated with increased or decreased lung cancer risk and may help prioritize candidate targets for future lung cancer drug development.
- Open Access
- 23 October 2025
- Published by IOP Publishing in Biomedical Materials
- Vol. 20 (6) , 065014
The sealing effect and degradation of polydioxanone weaving tracheal stents in a canine airway defect model
The use of covered self-expandable metal (CSEM) stents for fistulas sealing is a common clinical approach. However, these stents need to be removed once their therapeutic goals are achieved. Our study designed and fabricated a dumbbell-shaped, high-porosity, biodegradable polydioxanone weaving tracheal (PW) stent, and investigated its sealing efficacy and degradation characteristics. A tracheal defect model was created in 24 beagle dogs. Six dogs were implanted with CSEM stents, while the remaining 18 dogs received PW stents. The dogs in the CSEM and PW groups were observed for up to 8 and 14 weeks, respectively, with clinical symptoms, tracheoscopy, computed tomography scans, and fluoroscopy monitored. Subsequently, the stents were retrieved to observe morphological changes, and measure mechanical properties. The PW stents exhibited excellent airtightness, with significantly fewer complications such as stent displacement and granulation tissue hyperplasia compared to the CSEM stents. The tracheal tissue response to the PW stent was relatively mild. After PW stent implantation, collagen fiber deposition at the defect site gradually increased, and cartilage structure regeneration was observed in later stages. Notably, cilia were largely absent in the tracheal epithelium, with squamous metaplasia observed even in the later stages of the experiment following PW stent implantation. Additionally, the PW stents remained mostly intact in the canine airways until week 12, and were completely degraded and disappeared from the canine airways at week 14, without causing severe complications. The PW stent, featuring excellent biocompatibility and uniform degradation in the large-animal airway, demonstrated clinical effectiveness in sealing tracheal defects.
- 23 October 2025
- Published by IOP Publishing in Biomedical Materials
- Vol. 20 (6) , 065014
Open AccessThe sealing effect and degradation of polydioxanone weaving tracheal stents in a canine airway defect model
The use of covered self-expandable metal (CSEM) stents for fistulas sealing is a common clinical approach. However, these stents need to be removed once their therapeutic goals are achieved. Our study designed and fabricated a dumbbell-shaped, high-porosity, biodegradable polydioxanone weaving tracheal (PW) stent, and investigated its sealing efficacy and degradation characteristics. A tracheal defect model was created in 24 beagle dogs. Six dogs were implanted with CSEM stents, while the remaining 18 dogs received PW stents. The dogs in the CSEM and PW groups were observed for up to 8 and 14 weeks, respectively, with clinical symptoms, tracheoscopy, computed tomography scans, and fluoroscopy monitored. Subsequently, the stents were retrieved to observe morphological changes, and measure mechanical properties. The PW stents exhibited excellent airtightness, with significantly fewer complications such as stent displacement and granulation tissue hyperplasia compared to the CSEM stents. The tracheal tissue response to the PW stent was relatively mild. After PW stent implantation, collagen fiber deposition at the defect site gradually increased, and cartilage structure regeneration was observed in later stages. Notably, cilia were largely absent in the tracheal epithelium, with squamous metaplasia observed even in the later stages of the experiment following PW stent implantation. Additionally, the PW stents remained mostly intact in the canine airways until week 12, and were completely degraded and disappeared from the canine airways at week 14, without causing severe complications. The PW stent, featuring excellent biocompatibility and uniform degradation in the large-animal airway, demonstrated clinical effectiveness in sealing tracheal defects.
- Top Cited PapersOpen Access
- 21 May 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1605067
Pretreatment CALLY index as promising novel biomarker in the prediction of surgical and oncological outcomes in esophageal cancer: a multi-center retrospective cohort study
Background: Esophageal cancer (EC) is a global health challenge with high mortality rates. The traditional TNM staging system is limited in its ability to provide accurate prognostic predictions. This study aimed to investigate the utility of the C-reactive protein-albumin-lymphocyte (CALLY) index in the evaluation of mid- to long-term outcomes in patients undergoing esophagectomy.Methods: We conducted a multi-center retrospective cohort study of 657 EC patients admitted between 2010 to 2024, with 553 patients from Shanghai General Hospital (training cohort) and 104 from Shanghai Sixth People’s Hospital (validation cohort). Associations between the CALLY and overall survival (OS)/disease-free survival (DFS) were evaluated using multivariable-adjusted Cox regression analyses.Results: Patients with CALLY index > 2.55 were associated with significantly improved OS (adjusted hazard ratio [HR]: 0.55, 95% confidence interval [CI]: 0.43-0.71) and DFS (HR: 0.51, 0.40-0.65), independent of clinical risk factors. Incorporating CALLY index into clinical prediction models significantly enhanced discriminative ability (area under the receiver operating characteristic curve [AUROC] of OS: 0.719-0.752; AUROC of DFS: 0.745-0.788, P < 0.01). In the validation cohort, the same associations were also observed (HR of OS: 0.57, 95% CI: 0.42-0.78; HR of DFS: 0.53, 95% CI: 0.40-0.71). In both cohorts, CALLY index > 2.55 were associated with significantly reduced risk of recurrence.Conclusions: The CALLY index emerges as a cost-effective prognostic tool integrating inflammation-nutrition-immunity parameters. Its preoperative integration with tumor, node, and metastasis staging and other well-known risk factors might optimize risk stratification and guide personalized therapeutic strategies for EC patients undergoing esophagectomy.
- 21 May 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1605067
Top Cited PapersOpen AccessPretreatment CALLY index as promising novel biomarker in the prediction of surgical and oncological outcomes in esophageal cancer: a multi-center retrospective cohort study
Background: Esophageal cancer (EC) is a global health challenge with high mortality rates. The traditional TNM staging system is limited in its ability to provide accurate prognostic predictions. This study aimed to investigate the utility of the C-reactive protein-albumin-lymphocyte (CALLY) index in the evaluation of mid- to long-term outcomes in patients undergoing esophagectomy.Methods: We conducted a multi-center retrospective cohort study of 657 EC patients admitted between 2010 to 2024, with 553 patients from Shanghai General Hospital (training cohort) and 104 from Shanghai Sixth People’s Hospital (validation cohort). Associations between the CALLY and overall survival (OS)/disease-free survival (DFS) were evaluated using multivariable-adjusted Cox regression analyses.Results: Patients with CALLY index > 2.55 were associated with significantly improved OS (adjusted hazard ratio [HR]: 0.55, 95% confidence interval [CI]: 0.43-0.71) and DFS (HR: 0.51, 0.40-0.65), independent of clinical risk factors. Incorporating CALLY index into clinical prediction models significantly enhanced discriminative ability (area under the receiver operating characteristic curve [AUROC] of OS: 0.719-0.752; AUROC of DFS: 0.745-0.788, P < 0.01). In the validation cohort, the same associations were also observed (HR of OS: 0.57, 95% CI: 0.42-0.78; HR of DFS: 0.53, 95% CI: 0.40-0.71). In both cohorts, CALLY index > 2.55 were associated with significantly reduced risk of recurrence.Conclusions: The CALLY index emerges as a cost-effective prognostic tool integrating inflammation-nutrition-immunity parameters. Its preoperative integration with tumor, node, and metastasis staging and other well-known risk factors might optimize risk stratification and guide personalized therapeutic strategies for EC patients undergoing esophagectomy.
- Open Access
- 15 August 2024
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 22 (1) , 1-14
Tree-based ensemble machine learning models in the prediction of acute respiratory distress syndrome following cardiac surgery: a multicenter cohort study
Background: Acute respiratory distress syndrome (ARDS) after cardiac surgery is a severe respiratory complication with high mortality and morbidity. Traditional clinical approaches may lead to under recognition of this heterogeneous syndrome, potentially resulting in diagnosis delay. This study aims to develop and external validate seven machine learning (ML) models, trained on electronic health records data, for predicting ARDS after cardiac surgery. Methods: This multicenter, observational cohort study included patients who underwent cardiac surgery in the training and testing cohorts (data from Nanjing First Hospital), as well as those patients who had cardiac surgery in a validation cohort (data from Shanghai General Hospital). The number of important features was determined using the sliding windows sequential forward feature selection method (SWSFS). We developed a set of tree-based ML models, including Decision Tree, GBDT, AdaBoost, XGBoost, LightGBM, Random Forest, and Deep Forest. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) and Brier score. The SHapley Additive exPlanation (SHAP) techinque was employed to interpret the ML model. Furthermore, a comparison was made between the ML models and traditional scoring systems. ARDS is defined according to the Berlin definition. Results: A total of 1996 patients who had cardiac surgery were included in the study. The top five important features identified by the SWSFS were chronic obstructive pulmonary disease, preoperative albumin, central venous pressure_T4, cardiopulmonary bypass time, and left ventricular ejection fraction. Among the seven ML models, Deep Forest demonstrated the best performance, with an AUC of 0.882 and a Brier score of 0.809 in the validation cohort. Notably, the SHAP values effectively illustrated the contribution of the 13 features attributed to the model output and the individual feature's effect on model prediction. In addition, the ensemble ML models demonstrated better performance than the other six traditional scoring systems. Conclusions: Our study identified 13 important features and provided multiple ML models to enhance the risk stratification for ARDS after cardiac surgery. Using these predictors and ML models might provide a basis for early diagnostic and preventive strategies in the perioperative management of ARDS patients.
- 15 August 2024
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 22 (1) , 1-14
Open AccessTree-based ensemble machine learning models in the prediction of acute respiratory distress syndrome following cardiac surgery: a multicenter cohort study
Background: Acute respiratory distress syndrome (ARDS) after cardiac surgery is a severe respiratory complication with high mortality and morbidity. Traditional clinical approaches may lead to under recognition of this heterogeneous syndrome, potentially resulting in diagnosis delay. This study aims to develop and external validate seven machine learning (ML) models, trained on electronic health records data, for predicting ARDS after cardiac surgery. Methods: This multicenter, observational cohort study included patients who underwent cardiac surgery in the training and testing cohorts (data from Nanjing First Hospital), as well as those patients who had cardiac surgery in a validation cohort (data from Shanghai General Hospital). The number of important features was determined using the sliding windows sequential forward feature selection method (SWSFS). We developed a set of tree-based ML models, including Decision Tree, GBDT, AdaBoost, XGBoost, LightGBM, Random Forest, and Deep Forest. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) and Brier score. The SHapley Additive exPlanation (SHAP) techinque was employed to interpret the ML model. Furthermore, a comparison was made between the ML models and traditional scoring systems. ARDS is defined according to the Berlin definition. Results: A total of 1996 patients who had cardiac surgery were included in the study. The top five important features identified by the SWSFS were chronic obstructive pulmonary disease, preoperative albumin, central venous pressure_T4, cardiopulmonary bypass time, and left ventricular ejection fraction. Among the seven ML models, Deep Forest demonstrated the best performance, with an AUC of 0.882 and a Brier score of 0.809 in the validation cohort. Notably, the SHAP values effectively illustrated the contribution of the 13 features attributed to the model output and the individual feature's effect on model prediction. In addition, the ensemble ML models demonstrated better performance than the other six traditional scoring systems. Conclusions: Our study identified 13 important features and provided multiple ML models to enhance the risk stratification for ARDS after cardiac surgery. Using these predictors and ML models might provide a basis for early diagnostic and preventive strategies in the perioperative management of ARDS patients.
- Open Access
- 2 August 2024
- Published by IOP Publishing in Biomedical Materials
- Vol. 19 (5) , 055032
Study on in vivo and in vitro degradation of polydioxanone weaving tracheal stents
The appropriate degradation characteristics of polydioxanone (PDO) are necessary for the safety and effectiveness of stents. This study aimed to investigate the degradation of PDO weaving tracheal stents (PW stents) in vitro and in vivo. The degradation solution of S. aureus (SAU), E. coli (ECO), P. aeruginosa (PAE), and control (N) were prepared, and the PW stents were immersed for 12 weeks. Then, the radial support force, weight retention, pH, molecular structure, thermal performance, and morphology were determined. Furthermore, the PW stents were implanted into the abdominal cavity of rabbits, and omentum was embedded. At feeding for 16 weeks, the mechanical properties, and morphology were measured. During the first 8 weeks, the radial support force in all groups was progressively decreased. At week 2, the decline rate of radial support force in the experimental groups was significantly faster compared to the N group, and the difference was narrowed thereafter. The infrared spectrum showed that during the whole degradation process, SAU, ECO and PAE solution did not lead to the formation of new functional groups in PW stents. In vitro scanning electron microscope observation showed that SAU and ECO were more likely to gather and multiply at the weaving points of the PW stents, forming colonies. In vivo experiments showed that the degradation in the concavity of weaving points of PW stents was more rapid and severe. The radial support loss rate reached more than 70% at week 4, and the radial support force was no longer measurable after week 8. In omentum, multinuclear giant cells and foreign giant cells were found to infiltrate. PW stents have good biocompatibility. The degradation rate of PW stents in the aseptic conditions in vivo was faster than in the bacteriological environment in vitro.
- 2 August 2024
- Published by IOP Publishing in Biomedical Materials
- Vol. 19 (5) , 055032
Open AccessStudy on in vivo and in vitro degradation of polydioxanone weaving tracheal stents
The appropriate degradation characteristics of polydioxanone (PDO) are necessary for the safety and effectiveness of stents. This study aimed to investigate the degradation of PDO weaving tracheal stents (PW stents) in vitro and in vivo. The degradation solution of S. aureus (SAU), E. coli (ECO), P. aeruginosa (PAE), and control (N) were prepared, and the PW stents were immersed for 12 weeks. Then, the radial support force, weight retention, pH, molecular structure, thermal performance, and morphology were determined. Furthermore, the PW stents were implanted into the abdominal cavity of rabbits, and omentum was embedded. At feeding for 16 weeks, the mechanical properties, and morphology were measured. During the first 8 weeks, the radial support force in all groups was progressively decreased. At week 2, the decline rate of radial support force in the experimental groups was significantly faster compared to the N group, and the difference was narrowed thereafter. The infrared spectrum showed that during the whole degradation process, SAU, ECO and PAE solution did not lead to the formation of new functional groups in PW stents. In vitro scanning electron microscope observation showed that SAU and ECO were more likely to gather and multiply at the weaving points of the PW stents, forming colonies. In vivo experiments showed that the degradation in the concavity of weaving points of PW stents was more rapid and severe. The radial support loss rate reached more than 70% at week 4, and the radial support force was no longer measurable after week 8. In omentum, multinuclear giant cells and foreign giant cells were found to infiltrate. PW stents have good biocompatibility. The degradation rate of PW stents in the aseptic conditions in vivo was faster than in the bacteriological environment in vitro.
- Open Access
- 19 December 2023
- Published by Wiley in Cancer Medicine
- Vol. 13 (10)
Evaluating personalized circulating tumor DNA detection for early‐stage lung cancer
Circulating tumor DNA (ctDNA) has been widely used as a minimally invasive biomarker in clinical routine. However, a number of factors such as panel design, sample quality, patients' disease stages are known to influence ctDNA detection sensitivity. In this study, we systematically evaluated common factors associated with the variability of ctDNA detection in plasma and investigated ctDNA abundance in bronchoalveolar lavage (BAL). Whole exome profiling was conducted on 61 tumor tissue samples to identify tumor‐specific variants, which were then used to design personalized assay MarRyDa® for ctDNA detection. DNA extracted from BAL fluid and plasma were genotyped using MarRyDa® platform. Our analysis showed that histological subtypes and disease stages had significant differences in ctDNA detection rate. Furthermore, we found that DNA purified from BAL supernatants contains the highest levels of ctDNA compared with BAL precipitates and plasma; therefore, utilizing BAL supernatants for tumor detection might provide additional benefits. Finally, we demonstrated that tumor cellularity played significant roles in the design of personalized ctDNA panel which eventually impacts ctDNA detection sensitivity. We suggest setting a flexible criteria for sample quality control and utilization of BAL might benefit more patients in clinics.
- 19 December 2023
- Published by Wiley in Cancer Medicine
- Vol. 13 (10)
Open AccessEvaluating personalized circulating tumor DNA detection for early‐stage lung cancer
Circulating tumor DNA (ctDNA) has been widely used as a minimally invasive biomarker in clinical routine. However, a number of factors such as panel design, sample quality, patients' disease stages are known to influence ctDNA detection sensitivity. In this study, we systematically evaluated common factors associated with the variability of ctDNA detection in plasma and investigated ctDNA abundance in bronchoalveolar lavage (BAL). Whole exome profiling was conducted on 61 tumor tissue samples to identify tumor‐specific variants, which were then used to design personalized assay MarRyDa® for ctDNA detection. DNA extracted from BAL fluid and plasma were genotyped using MarRyDa® platform. Our analysis showed that histological subtypes and disease stages had significant differences in ctDNA detection rate. Furthermore, we found that DNA purified from BAL supernatants contains the highest levels of ctDNA compared with BAL precipitates and plasma; therefore, utilizing BAL supernatants for tumor detection might provide additional benefits. Finally, we demonstrated that tumor cellularity played significant roles in the design of personalized ctDNA panel which eventually impacts ctDNA detection sensitivity. We suggest setting a flexible criteria for sample quality control and utilization of BAL might benefit more patients in clinics.
- Open Access
- 16 July 2022
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 13 (3) , 96
A Review of Woven Tracheal Stents: Materials, Structures, and Application
The repair and reconstruction of tracheal defects is a challenging clinical problem. Due to the wide choice of materials and structures, weaving technology has shown unique advantages in simulating the multilayer structure of the trachea and providing reliable performance. Currently, most woven stent-based stents focus only on the effect of materials on stent performance while ignoring the direct effect of woven process parameters on stent performance, and the advantages of weaving technology in tissue regeneration have not been fully exploited. Therefore, this review will introduce the effects of stent materials and fabric construction on the performance of tracheal stents, focusing on the effects of weaving process parameters on stent performance. We will summarize the problems faced by woven stents and possible directions of development in the hope of broadening the technical field of artificial trachea preparation.
- 16 July 2022
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 13 (3) , 96
Open AccessA Review of Woven Tracheal Stents: Materials, Structures, and Application
The repair and reconstruction of tracheal defects is a challenging clinical problem. Due to the wide choice of materials and structures, weaving technology has shown unique advantages in simulating the multilayer structure of the trachea and providing reliable performance. Currently, most woven stent-based stents focus only on the effect of materials on stent performance while ignoring the direct effect of woven process parameters on stent performance, and the advantages of weaving technology in tissue regeneration have not been fully exploited. Therefore, this review will introduce the effects of stent materials and fabric construction on the performance of tracheal stents, focusing on the effects of weaving process parameters on stent performance. We will summarize the problems faced by woven stents and possible directions of development in the hope of broadening the technical field of artificial trachea preparation.
- 12 May 2020
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 26, e923967-e923967-8
Clinical Experience with Thymic Cystectomy: A Single-Institution Study of 117 Cases from 2013 to 2019
Background: The aim of this study was to summarize the clinical experience of thymic cysts treatment from a single center. Material/Methods: Clinical data, imaging, pathological results, and follow-up results of thymic cyst patients who underwent surgery from January 2013 to September 2019 were retrospectively reviewed. Results: A total of 117 patients were enrolled, including 76 asymptomatic patients and 41 symptomatic patients. The average diameter of thymic cysts, the cysts in asymptomatic patients, and those in symptomatic patients were 31.93 +/- 19.92 mm, 29.28 +/- 17.97 mm, and 36.85 +/- 22.50 mm, respectively. The number of cysts ranged from 1 to 3 cm, 3 to 6 cm, and >6 cm in 73 cases (62.4%), 32 cases (27.3%), and 12 cases (10.3%), respectively. There was no correlation between the size of thymic cysts and the presence or absence of symptoms. Only 20 cases (17.1%) were correctly diagnosed as thymic cysts before surgery. There were 67 patients (57.3%) who underwent video-assisted thoracic surgery (VATS) and 50 cases (42.7%) underwent open surgery. Cystectomy was performed in 93 cases (79.5%) and 24 cases (20.5%) underwent simultaneous resection of thymic cysts and other thoracic tumors. Compared with the thoracotomy group, the VATS group had shorter hospital stay and chest tube indwelling time. No serious complications occurred after surgery. The median follow-up time was 45.0 months (range 4.0-84.0 months) and there was no recurrence. Conclusions: Attention should be paid to the accuracy of preoperative diagnosis of thymic cysts and the reduction of asymptomatic thymic cystectomy. For patients who have both thymic cysts and other thoracic tumors, simultaneous surgery is safe and feasible.
- 12 May 2020
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 26, e923967-e923967-8
Clinical Experience with Thymic Cystectomy: A Single-Institution Study of 117 Cases from 2013 to 2019
Background: The aim of this study was to summarize the clinical experience of thymic cysts treatment from a single center. Material/Methods: Clinical data, imaging, pathological results, and follow-up results of thymic cyst patients who underwent surgery from January 2013 to September 2019 were retrospectively reviewed. Results: A total of 117 patients were enrolled, including 76 asymptomatic patients and 41 symptomatic patients. The average diameter of thymic cysts, the cysts in asymptomatic patients, and those in symptomatic patients were 31.93 +/- 19.92 mm, 29.28 +/- 17.97 mm, and 36.85 +/- 22.50 mm, respectively. The number of cysts ranged from 1 to 3 cm, 3 to 6 cm, and >6 cm in 73 cases (62.4%), 32 cases (27.3%), and 12 cases (10.3%), respectively. There was no correlation between the size of thymic cysts and the presence or absence of symptoms. Only 20 cases (17.1%) were correctly diagnosed as thymic cysts before surgery. There were 67 patients (57.3%) who underwent video-assisted thoracic surgery (VATS) and 50 cases (42.7%) underwent open surgery. Cystectomy was performed in 93 cases (79.5%) and 24 cases (20.5%) underwent simultaneous resection of thymic cysts and other thoracic tumors. Compared with the thoracotomy group, the VATS group had shorter hospital stay and chest tube indwelling time. No serious complications occurred after surgery. The median follow-up time was 45.0 months (range 4.0-84.0 months) and there was no recurrence. Conclusions: Attention should be paid to the accuracy of preoperative diagnosis of thymic cysts and the reduction of asymptomatic thymic cystectomy. For patients who have both thymic cysts and other thoracic tumors, simultaneous surgery is safe and feasible.